Psoriasis Treatment Market Size to Hit USD 54.40 Billion by 2032 Driven by Advances in Biologic and Innovative Therapies – SNS Insider [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Psoriasis Treatment Market Overview: According to SNS Insider, The Psoriasis Treatment Market was worth USD 22.38 billion in 2023, is projected to grow to USD 54.40 billion by 2032 at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2032. The massive growth is largely due to the increasing prevalence of psoriasis globally and huge improvements in biologic treatments with improved efficacy and safety profiles. Psoriasis, a long-term autoimmune skin disease, impacts millions of people worldwide, causing physical distress and affecting the quality of life. Growing awareness of psoriasis as a significant health issue has driven research and development efforts, leading to new treatment alternatives. Biologic drugs, focusing on specific elements of the immune system, have transformed the treatment of psoriasis, offering patients more effective and specific therapies. Get a Sample Report of Psoriasis Treatment Market@ https://www.sns
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Is AbbVie a Buy, Sell, or Hold in 2026? [Yahoo! Finance]Yahoo! Finance
- Top Stock Reports for AbbVie, Coca-Cola & Chevron [Yahoo! Finance]Yahoo! Finance
- 2 Dividend Kings Quietly Beating the Market This Year [Yahoo! Finance]Yahoo! Finance
- What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- ????????????????????????????2035????128???????????? [CNET News]CNET News
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 11/20/25 - Form F-6
- 11/4/25 - Form 10-Q
- 10/31/25 - Form 8-K
- ABBV's page on the SEC website